To generate an improved gating strategy, we applied linear discriminant analysis with hybrid subset selection (HSS-LDA)23,24 to discriminate neoplastic and normal CD4+ T cells in leukemic CTCL patients and HCs (Figure S2B). Here, CD4 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.